Collaborations Pharmaceuticals, Inc.
Publicly observedFuquay Varina, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Fuquay Varina | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Collaborations Pharmaceuticals, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | EFJCLL37KKH3 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Sept 2026Publicly observed
NIH SBIR/STTR award: Long-term formulation for combination antiviral treatment of HIV
USD 306,870.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant8 Mar 2024Publicly observed
NIH SBIR/STTR award: Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
USD 2,112,893.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant10 Dec 2021Publicly observed
NIH SBIR/STTR award: Machine learning approaches to predict Acetylcholinesterase inhibition and model applications
USD 1,317,335.00 · National Institute of Environmental Health Sciences · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.